Recordati 주식 가격. REC - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

개인 투자자를 위한 전문가급 도구.

프리미엄

가격

51.90

매수가

51.85

매도가

53.00

거래량

157,577

52.00 일간 변동폭 52.70

43.67 52주 범위 54.80

market_cap

10.658B

전일 종가

52.65

개장가

52.35

최근 거래 시간

203

51.9

마지막 거래 시간

재정 규모

VWAP

평균 볼륨(3m)

221,223

발행 주식

205,358,104

배당수익률

2.31%

주가수익률

27.57

주당순이익(EPS)

1.9

매출

2.07B

순이익

389.21M

섹터

Pharmaceutical Preparations

산업

Pharmaceutical Preparations

웹사이트

www.recordati.it

본부

Milan, Lombardy, Ita

설립됨

1926

Recordati SpA is listed in the Pharmaceutical Preparations sector of the 이탈리아 증권거래소 with ticker REC. The last closing price for Recordati was 52.65 €. Over the last year, Recordati shares have traded in a share price range of 43.67 € to 54.80 €.

Recordati currently has 205,358,104 shares in issue. The market capitalisation of Recordati is 10.81 € billion. Recordati has a price to earnings ratio (PE ratio) of 27.57.

RECORDATI ANNOUNCES AGREEMENT TO ACQUIRE THE GLOBAL RIGHTS TO ENJAYMO®, STRENGTHENING ITS RARE DISEASES FRANCHISE

RECORDATI ANNOUNCES AGREEMENT TO ACQUIRE THE GLOBAL RIGHTS TO ENJAYMO®, STRENGTHENING ITS RARE DISEASES FRANCHISE Milan, 4th October 2024 – Recordati today announces an agreement with Sanofi...

Recordati Rare Diseases: Ergebnisse der Phase-III-Studie LINC 4 im Journal of Clinical Endocrinology & Metabolism veröffentlicht; Bestätigung der Wirksamkeit und Sicherheit von Isturisa® (Osilodrostat) bei Patienten mit Morbus Cushing

Die LINC-4 Studie belegt die Überlegenheit von Isturisa® (Osilodrostat) gegenüber Placebo mit Blick auf die Normalisierung des Cortisolspiegels während der 12-wöchigen, doppelblinden...

RECORDATI: POSITIVE RESULTS FROM THE PHASE III LINC 4 STUDY PRESENTED AT THE ENDOCRINE SOCIETY’S ANNUAL MEETING REINFORCE ...

RECORDATI: POSITIVE RESULTS FROM THE PHASE III LINC 4 STUDY PRESENTED AT THE ENDOCRINE SOCIETY’S ANNUAL MEETING REINFORCE THE EFFICACY AND SAFETY OF ISTURISA® (OSILODROSTAT) IN CUSHING’S...

Recordati Rare Diseases: Positive Ergebnisse aus der Phase-III-Studie LINC 4, die heute auf der Jahrestagung der Endocrine So...

Statistisch signifikante Ergebnisse aus der Phase-III-Studie LINC 4 zeigen, dass Isturisa® (Osilodrostat) bei der Mehrzahl der Patienten eine schnelle und anhaltende Normalisierung der mittleren...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-2.05	-3.79981464319	53.95	54.45	51.6	207270	53.20673427	DE
4	-0.2	-0.383877159309	52.1	54.8	51.6	250691	53.35280412	DE
12	2.42	4.89086499596	49.48	54.8	49.06	221223	51.90194716	DE
26	1	1.96463654224	50.9	54.8	47.28	236410	50.63255766	DE
52	7.91	17.9813593999	43.99	54.8	43.67	231276	49.90823898	DE
156	-4.8	-8.46560846561	56.7	57.22	34.52	234670	45.85393765	DE
260	14.87	40.1566297597	37.03	57.9	28.26	284039	44.51311539	DE

가장 활성
% 상승자
% 패자

기호	가격	볼륨
WDIT24Destination Italia Spa	0.004 € (207.69%)	181.92k
1FISVFiserv Inc Dl 01	188.00 € (20.51%)	132
PORPortobello SPA	2.85 € (19.75%)	60.15k
WSGC28SG Company SpA	0.0348 € (17.97%)	1
EPRBEprcomunicazione spa	1.35 € (17.39%)	55.65k
AIMAA4aim Sicaf SpA	0.07 € (-69.57%)	2.05k
WSOS24Sostravelcom SpA	0.05 € (-27.85%)	13.15k
WS3D25Solid World Group spa	0.111 € (-24.34%)	5.8k
1JAMJetblue Awys Corp Dl 01	5.273 € (-23.95%)	239
1ANTMElevance Health Inc	385.00 € (-21.43%)	1
ISPIntesa Sanpaolo Spa	4.076 € (1.05%)	96.55M
TITTelecom Italia SpA	0.2319 € (-0.69%)	84.74M
SPMSaipem Spa	2.229 € (0.32%)	41.7M
ENELEnel Spa	7.023 € (0.16%)	14.93M
TITRTelecom Italia	0.2679 € (-0.30%)	11.42M